Effectiveness of maternal pertussis vaccination in protecting newborn: A matched case-control study

Introduction: The objective was to estimate the effectiveness of maternal pertussis vaccination in pro- tecting infants aged < 2 months. Methods: We performed a case-control study. Laboratory-confirmed cases aged <8 weeks at disease onset were identified and 2–4 matched-controls born within ±...

ver descrição completa

Detalhes bibliográficos
Autores: Godoy i García, Pere, García Cenoz, Manuel, Rius, Cristina, Muñoz Almagro, Carmen, Carmona, Gloria, Alsedà Graells, Miquel, Jané, Mireia, Vidal, Maria José, Rodríguez, Raquel, Álvarez, Josep, Camps, Neus, Minguell, Sofia, Carol, Monica, Sala, Maria Rosa, Castilla, Jesús, Domínguez, Angela
Formato: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2021
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10459.1/469388
Acesso em linha:https://doi.org/10.1016/j.jinf.2021.08.022
https://hdl.handle.net/10459.1/469388
Access Level:acceso abierto
Palavra-chave:Maternal pertussis vaccination
Newborn
Pertussis
Vaccine
Vaccine effectiveness
Descrição
Resumo:Introduction: The objective was to estimate the effectiveness of maternal pertussis vaccination in pro- tecting infants aged < 2 months. Methods: We performed a case-control study. Laboratory-confirmed cases aged <8 weeks at disease onset were identified and 2–4 matched-controls born within ± 15 days of the case were included. Information was obtained from healthcare providers and maternal interviews. Odds ratios (OR) were calculated using multivariable conditional logistic regression. Vaccine effectiveness (VE) was estimated as (1 – OR) × 100%. Results: 47 cases and 124 controls were studied. The mean age (in days) (39.8 ± 12.7 vs. 40.8 ± 13.2), weeks of gestation (38.8 vs. 39.1, p = 0.43) and mean birth weight (3.309 vs. 3.253 kg, p = 0.55) were comparable between cases and controls. Mothers of cases were less frequently vaccinated in the third trimester (59.6% vs. 83.9%, p <0.001). The VE of maternal vaccination in pregnancy was 88.0% (95%CI 53.8% -96.5%), and was slightly higher in those vaccinated before the 32nd week of gestation (88.5% vs 87.8%). Conclusion: Pertussis vaccination in pregnancy is very effective in reducing pertussis in children aged < 2 months. Vaccination before and after the 32nd week of pregnancy are equally effective in reducing the risk of pertussis.